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Abstract: The facile synthesis and detailed investigation of a class of highly potent protease inhibitors
based on 1,4-naphthoquinones with a dipeptidic recognition motif (HN-l-Phe-l-Leu-OR) in the
2-position and an electron-withdrawing group (EWG) in the 3-position is presented. One of the
compound representatives, namely the acid with EWG = CN and with R = H proved to be a
highly potent rhodesain inhibitor with nanomolar affinity. The respective benzyl ester (R = Bn) was
found to be hydrolyzed by the target enzyme itself yielding the free acid. Detailed kinetic and mass
spectrometry studies revealed a reversible covalent binding mode. Theoretical calculations with
different density functionals (DFT) as well as wavefunction-based approaches were performed to
elucidate the mode of action.
Keywords: protease; rhodesain; covalent reversible inhibition; 1,4-naphthoquinone; nucleophilic
addition; prodrug
1. Introduction
Covalently acting drugs have traditionally been considered as problematic due to their potential to
elicit off-target effects. In the last years, however, such compounds have received increasing attention
in drug development due to several advantages including longer target residence times, higher potency
and ligand efficiency. It has been recognized that the benefits of such inhibitors can be additionally
enhanced by careful tuning of their reactivity, i.e., by switching the covalent inhibition mode from
covalent irreversible to covalent reversible [1–8].
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In general, covalent inhibitors consist of two parts, namely a recognition unit fitting into the
substrate binding pockets, and an electrophilic functional group. In the case of protease inhibitors,
the recognition unit is typically a peptidic or peptidomimetic fragment. Covalent inhibitors also
contain an electrophilic functional group (the so-called “warhead”), which can undergo a chemical
reaction with a nucleophilic amino acid in the vicinity. In most cases, Cys, Ser or Thr side chains are
addressed. A large fraction of the known types of warheads targeting Cys residues is based on activated
double bonds (Michael acceptors) [9] comprising, e.g., vinyl sulfones [10–12], α,β-unsaturated esters,
nitriles and ketones [13–16]. Depending on the substitution pattern of the double bond, the inhibition of
the target enzyme can either be covalent reversible or irreversible [17]. Heterocyclic or peptide-derived
nitriles constitute another important substance class of protease inhibitors, which inhibit cysteine and
serine proteases in a covalent reversible manner via the formation of a (thio) imidate [18–21].
In the present study, we compared chloro- and nitrile-substituted peptidyl 1,4-naphthoquinones
with respect to their inhibition properties. In principle, such multifunctional warheads [22] could
undergo either Michael-type additions or substitution reactions or—in case of the nitrile derivative—also
reversible addition to the nitrile group.
We explored the potential of such groups as new warheads for cysteine proteases of the papain
family, namely the human cathepsins L and B (Cath. L and Cath. B), and the cathepsin L-like
Trypanosoma protease rhodesain (Rhod.). The human enzymes of this family play crucial roles in,
e.g., tumor metastasis [23,24]. Rhodesain from Trypanosoma brucei rhodesiense, the parasite causing
human African trypanosomiasis (HAT), is essential for the parasite’s survival as it is involved in several
host invasion processes [25,26]. In order to check the selectivity, the inhibition potencies of the new
inhibitors were also tested for the serine protease of the Dengue virus (DENV PR) [27,28].
Since we were interested in the inhibition properties of the two warheads, we used the same
recognition unit, the dipeptide sequence H2N-l-Phe-l-Leu-OBn and attached the 1,4-naphthoquinone
unit to its N-terminus. This dipeptide sequence was chosen since it was previously shown to be an
appropriate recognition unit for cathepsin-like cysteine proteases [29,30]. Moreover, as opposed to
amino acids with functionalized side chains, no additional protection/deprotection steps are necessary
during synthesis. We previously observed that rhodesain is able to hydrolyze compounds with the
dipeptidic H2N-l-Phe-l-Leu-OBn recognition unit [30]. In agreement with these findings, we also
observed the protease-mediated hydrolysis of the benzyl ester moieties of the naphthoquinone-modified
inhibitors to yield the free acids (see Sections 2.4 and 2.6). We therefore additionally compared the free
acids as well as the respective methyl and tert-butyl esters of our current molecules for their ability to
inhibit rhodesain.
Mass spectrometry revealed the formation of a covalent bond between the inhibitors and rhodesain.
We therefore also computed the thermodynamics of possible inhibition reactions to gain insights into
the energetics of the various possible covalent inhibition mechanisms. The chemical properties of such
groups are strongly influenced by their degree of aromatic stabilization, which is often overestimated by
standard density functional approaches [31]. To evaluate which theoretical approaches are sufficiently
reliable to predict the inhibition mechanisms and potencies of such groups, a benchmark study
employing various wave functions as well as density-based approaches were performed.
2. Results
2.1. Syntheses
The dipeptide product H2N-l-Phe-l-Leu-OBn was synthesized as reported previously [30].
The potential inhibitors were synthesized by an addition/elimination reaction on the naphthoquinone
unit carrying two potential leaving groups (Scheme 1).
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Scheme 1. Syntheses of potential protease inhibitors with naphthoquinone units as the reactive group.
The respective methyl and tert-butyl esters 5–8 were synthesized accordingly. To further investigate
whether the hydrolysis products of the benzyl esters 1 and 2 are the active compounds as indicated by
the MS and hydrolysis studies (see Sections 2.4 and 2.6), the corresponding free acids 3 and 4 were
also synthesized.
2.2. Enzyme Assays
Enzyme inhibition by the benzyl esters 1 and 2 was tested with the fluorogenic
substrate Cbz-Phe-Arg-AMC as described previously [18,30]. First, assays with 20 µM inhibitor
concentration were performed. For compounds displaying > 60% inhibition at that concentration,
concentration-dependent assays were performed and IC50 values as well as detailed kinetic constants
(Ki, Ki* and k3/4) were determined (Tables 1 and 2). The IC50 values (In case of time-dependent inhibition,
the steady-state residual enzyme activities (vS) were used for determination of the IC50 values) were
determined at different substrate concentrations in order to check for competitive or non-competitive
inhibition [32,33]. The values were found to increase linearly with increasing substrate concentrations,
indicating competitiv inhi ition (se exemplarily Figure 1 for inhibition of cathepsin L by benzyl
esters 1 and 2). The espective Ki(*) values (Table 1) were determined from plots of the IC50 values
against the substrate concentration according to the Cheng–Prusoff relationship (Figure 1) [34].
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concentrations prove competitive inhibition; the Ki(*) value (corresponding to the IC50 value at zero 
substrate concentration) is obtained as the intercept of the regression line with the y-axis (a: Ki = 1.14 
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In order to check the cross-reactivity against serine proteases, we determined the potency of the
compounds to inhibit the NS3/NS2B protease of the Dengue virus (DENV PR) [27,28].
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Table 1. Inhibition data for 1,4-naphthoquinone (NQ)-derived inhibitors of the general structure
NQ-NH-l-Phe-l-Leu-OR, % inhibition at 20 µM or Ki(*) (nM) 1.
Cpd. Cath. L% inh.
Cath. L
Ki(*)
Cath. B
% inh.
Cath. B
Ki(*)
Rhod.
% inh.
Rhod.
Ki(*)
DENV PR
% inh.
DENV PR
Ki(*)
1 1140 53% 2900 41% Nd
2 33 3 1900 180 41,000 2
3 57 3 25% Nd 24 3 43% Nd
4 17 3 45% Nd 0.15 3 38% Nd
5 45% Nd Nd Nd 48% Nd Nd Nd
6 40% Nd Nd Nd 1235 Nd Nd
7 38% Nd Nd Nd 51% Nd Nd Nd
8 21% Nd Nd Nd 38% Nd Nd Nd
1 All values are from at least three independent measurements; standard deviations are 15% or less in case of Ki
values and 5% or less in case of % inhibition @ 20 µM; IC50 values and Ki(*) values were determined for compounds
displaying > 60% inhibition at 20 µM; 2 IC50 value in nM at [S] = 100 µM (Boc-Gly-Arg-Arg-AMC); 3 reversible,
time-dependent inhibition; the Ki* values for the final high-affinity complexes are given as mean values from
method 1 and method 2 (see Section 2.2); for more detailed inhibition constants see Table 2. Cpd., compound;
Cath. L, cathepsin L; Cath. B, cathepsin B; Rhod., rhodesain; DENV PR, Dengue virus protease. Nd, not determined.
For the two benzyl esters 1 and 2, the highest inhibition was found for cathepsin L with the nitrile
substituted quinone 2 (Ki* ca. 30 nM). Both esters also inhibited cathepsin B and rhodesain, however
with lower inhibitory potencies compared to cathepsin L. Still, the nitrile derivative 2 exhibited the
higher inhibition efficiency. Very low inhibition was found for the DENV PR.
The progress curves for inhibition of cathepsin L were found to be non-linear in case of the
nitrile-substituted benzyl ester 2, i.e., time-dependent inhibition was observed (see Figure 2).
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Figure 2. Progres curves for inhibiti sin by compound 2. The f llowing inhibitor
concentrations were teste top to bottom): 0. 1–0.05 0.1– .25–0.5–1.0–2 5 µM. For clarity,
the residual initial (vi, blue) and the residual steady-state (vS, red) velocities are shown exemplarily for
the progress curve at [I] = 2.5 µM.
Non-linear progress curves indicate a covalent inhibition mechanism (resulting either from
covalent reversible or covalent irreversible inhibition), or indicate a slow/tight-binding non-covalent
reversible inhibition. In case of an irreversible inhibition, the progress curves should reach a plateau
value with the terminal residual enzyme activity, i.e., the steady-state velocity of substrate turnover
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in the presence of the inhibitor, vS = 0. In the case of reversible inhibition, the progress curves may
also reflect a time-dependent inhibition if a two-step mechanism of inhibition occurs. In these cases,
the second step reflects the reversible covalent reaction between a nucleophilic amino acid of the
enzyme and the electrophilic warhead of the inhibitor or it reflects the inhibition due to a non-covalent
high-affinity complex, e.g., resulting from large conformational changes. In such cases, the progress
curves display a biphasic behavior with the terminal residual enzyme activity in the presence of the
inhibitor vS , 0, but with vS < vi (with vi being the initial residual enzyme activity in the presence
of the inhibitor, Figure 2). The two scenarios, i.e., irreversible and reversible two-step mechanism,
may not be distinguished easily when only the progress curves are regarded, requiring additional
investigations of the (ir)reversibility of the inhibition, e.g., by dialysis or dilution assays [35].
In order to verify the (ir)reversibility of inhibition, we thus performed dilution assays with
cathepsin L and both inhibitors 1 and 2, as well with rhodesain and chloro-derivative 1. These assays
showed full reactivation of the enzyme activity in the case of cathepsin L for both inhibitors 1 and 2
(see Figure 3), but only partial reactivation (40–50%) in the case of rhodesain and the chloro-derivative 1
(data not shown).
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Figure 3. Dilution assays to prove reversible inhibition. Cathepsin L was incubated (15 min) with
an excess of inhibitor 1 or 2, respectively (five times the IC50 concentration) to ensure full inhibition.
Then, the mixture was diluted by 50-fold to yield a final inhibitor concentration of 10% of the IC50
concentration. The enzyme activity, measured through addition of the substrate, nearly fully recovered
in case of inhibitors 1 and 2, whereas in case of the irreversible inhibitor K11777, a well-known vinyl
sulfone [36], o recovery was observed.
The biphasic behavior observed in the progress curve for inhibition of cathepsin L by compound 2
(Figure 2) with the steady-state velocit of substrate turnove vS , 0, indicates a rever ibl two-step
mechani m, which was supported by the dilution assays. We calculated the dissociation const nts of
the initial non-covalent enzyme-inhibitor complex Ki (=
k2
k1
) and of the final, high-affinity complex Ki*.
E+ I
k1

k2
E︸      ︷︷      ︸
ki
−−−I k3

k4
E− I
︸                          ︷︷                          ︸
K∗i
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To this end, we determined the initial and steady-state velocities (vi and vS) in the presence of the
inhibitor (Figure 2) as well as the pseudo-first order rate constants kobs of inhibition for seven different
inhibitor concentrations [I] by fitting the progress curves (Figure 2) to Equation (1) [37,38]:
[P] = vs ∗ t+ vi − vskobs [1− exp(−kobs ∗ t)] + o f f set (1)
The kobs values were fitted against the inhibitor concentrations [I] (Figure 4) with Equation (2) [37]:
kobs = k4 + (
k3 ∗ [I]
Kappi + [I]
) (2)
to yield the apparent dissociation constant Kiapp of the initial enzyme–inhibitor complex, as well as the
rate constants k3 and k4 of the second inhibition step (method 1).
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Figure 4. Example of a replot of the kobs values for the progress curves from Figure 2 as a function of
inhibitor concentration. The intercept with the y-axis provides an estimate of k4, while the maximum
value of kobs at infinite inhibitor concentration reflects the sum of k3 and k4. The concentration of
inhibitor yielding a half-maximal value of kobs is equal to Kiapp.
Since the compound displays competitive inhibition with respect to the substrate (see Figure 1),
the Kiapp value could be converted to Ki for the initial inhibitor encounter complex with the
Cheng–Prusoff eq ation (Equation (3)) [34]:
Ki =
Kappi
1+ [S]Km
(3)
The Ki* value as the dissociation constant of the final high-affinity complex was calculated from
Equation (4):
K∗i =
Ki
1+ ( k3k4 )
(4)
Both dissociation constants, Ki and Ki*, were also obtained (method 2) by fitting the initial (vi) and
steady-state (vS) velocities, respectively, against the inhibitor concentrations using the Dixon equation
(Equation (5)) [32,33]:
vi,s
v0
=
[I]
1+ ( [I]
K(∗)appi
)
(5)
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In order to obtain Kiapp (from fitting vi against [I]) and Ki*app (from fitting vs. against [I]) with v0 as
the substrate turnover velocity in the absence of the inhibitor. The apparent dissociation constants were
again converted into the true dissociation constant using the Cheng–Prusoff equation (Equation (3)).
The following results were obtained:
Method 1: Ki = 0.16 µM; Ki* = 0.012 µM; k3 = 0.0148 s−1; k4 = 0.0012 s−1;
Method 2: Ki = 0.30 µM; Ki* = 0.054 µM.
The results show, that there is good conformity between the two methods for determination of
Ki and Ki* values. The data show that compound 2 displays a two-step inhibition mechanism on
cathepsin L with a high affinity (0.012 µM (method 1)/0.054 µM (method 2); i.e., ca. 0.03 µM as mean
value) of the final complex and a half-life t1/2 of ca. 570 s, i.e., around 10 min(calculated by t1/2 = 0.693k4 ).
Assuming that the forward and the backward reaction proceed along the same reaction path and
that their kinetic prefactors are equal, the quotient of k3 and k4 can be used to estimate the reaction
energy ∆Ereac of the second inhibition step by Equation (7), which is derived from Equation (6):
k3
k4
=
A3 exp
(
−∆E
A
3
RT
)
A4 exp
(
−∆E
A
4
RT
) = exp∆EA4 − ∆EA3RT
 = exp(∆EreacRT
)
(6)
∆Ereac = ln
(
k3
k4
)
RT (7)
In Equation (6), ∆EA3 and ∆E
A
4 are the corresponding reaction barriers of the second inhibition
step; their difference corresponds to the reaction energy ∆Ereac of this step. Using the k3 and k4 values
measured for 2, a reaction energy ∆Ereac of about −1.5 kcal/mol was obtained.
Table 2. Detailed inhibition data for the time-dependent inhibition of cathepsin L and rhodesain by
1,4-naphthoquinone (NQ)-derived inhibitors of the general structure NQ-NH-l-Phe-l-Leu-OR 1..
Cpd. Cath. L Rhod.
Ki/Ki*
Method 1
Ki/Ki*
Method 2
k3/k4
t1/2/
∆Ereac
Ki/Ki*
Method 1
Ki/Ki*
Method 2
k3/k4
t1/2/
∆Ereac
2 160/12 300/54 0.0148/0.0012 570/−1.5 Nd Nd Nd Nd
3 443/53 345/61 0.0052/0.0007
990/
−1.2 57/11 63/36
0.0025/
0.0006 1155/−0.85
4 129/19 91/15 0.0051/0.0009
770/
−1.1 0.47/0.10 0.32/0.20
0.0027/
0.0006 1155/−0.89
1 Ki(*) values in nM; k3, k4 in 1/s, t1/2 in s, ∆Ereac in kcal/mol; values are mean values from at least five independent
measurements with standard deviations 15% or less. Nd, not determined.
2.3. Mass Spectrometry with Benzyl Esters 1 and 2
To further characterize the interaction between rhodesain and the two benzyl ester-based
inhibitors 1 and 2, we performed a liquid-chromatography–mass spectrometric (LC–MS) analysis of
rhodesain that had been incubated with the compounds. Rhodesain without an inhibitor served as a
control. Both compounds reacted with rhodesain (Figure 5).
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2109.9 ± 20 ppm) in the abs nce (orange) or presence (blue) of compounds 1 (A) and 2 (B). The addition
of compoun resulted in mas shifts of (A) m/z 42.56 (corresponding to 468.27 Da) and (B)
m/z . r sponding to 459.14 Da), in both cases indicating the formation of an a duct between
rhodesain d the ydrolysis product (i.e., the acid) of the respecti d.
Interestingly, for b th investigated compounds we found that rhodesain catalyzed the hy rolysis
of the benzyl ester of the dipeptide recognition unit t the corresponding acid, indicated by a mass shift
of 90 Da corresponding to the loss of the terminal benzyl group (Figure 5). Notably, only adducts of the
hydrolysis products (i.e., the acids) with rhodesain were detectable by LC–MS analysis. This is in full
agreement with previous results, which also revealed enzyme-catalyzed hydrolysis of peptidic benzyl
esters with electrophilic warhead by rhodesain yielding free acids as highly active inhibitors [30].
2.4. Enyzme Assays with Acids 3 and 4, and Esters 5–8
In order to investigate whether this inhibition mode is also found for other esters, we synthesized
and tested the respective methyl and tert-butyl esters 5–8. None of these compounds was found to
significantly inhibit either cathepsin L or rhodesain at 20 µM.
The free acids 3 and 4, which were identified via mass spectrometry as rhodesain inhibitors
emerging through hydrolysis of the benzyl esters by the target enzyme, were synthesized and tested.
While in the case of cathepsin L, we observed a 20-fold improvement for the chloro-derivative 3
compared to the ester 1 (1140 vs. 57 nM), the nitrile-substituted acid 4 turned out to be comparable in
pote cy to its benzyl ester 2 (33 vs. 17 nM). In agreement with previous findings [30], the inhibiti of
rhodesain was extraordinarily improved with the two acid derivatives 3 and 4 (with 2900 vs. 24 nM ca.
120-fold for the chloro-derivative 3 compared to the ester 1, with 180 vs. 0.15 nM ca. 1200-fold for the
nitrile derivative 4 compared to the ester 2). For cathepsin B and the DENV PR no improvement in
inhibition was observed.
Dilution assays with the five-fold IC50 concentrations and 50-fold dilution for the carboxylic acid
inhibitors 3 and 4 were performed on both, cathepsin L and rhodesain. These assays showed full
reactivation of the enzyme activity for both inhibitors on both enzymes (data not shown). To strengthen
the statement of reversible inhibition, we performed dialysis assays with the 20-fold concentration
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of the IC50 of inhibitor 3 or 4 and rhodesain (Figure 6). For both compounds, 3 and 4, the enzymatic
activity was restored by dialyzing the inhibitor from the reaction vessel. In the case of compound 4,
i.e., the highly potent nitrile-derivative, only slow reactivation was observed. In the case of the known
irreversible inhibitor K11777 [36,39], the enzyme activity could not be recovered.
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Figure 6. Dialysis assay to investigate the reversibility of the inhibition. Rhodesain was preincubated
(30 min) with inhibitor 3, 4 or K11777, respectively, (20 times the IC50 concentration). Then, the mixture
was dialyzed in a self-made dialysis chamber [35]. The enzyme activity of all samples was determined
relatively to the DMSO treated sample (0 min) by a fluorometric enzyme assay.
Both acids were found to inhibit both enzymes, cathepsin L and rhodesain, reversibly (Figure 6),
but time-dependently (Figure 7A,C,E; see Tables 1 and 2 for detailed kinetic data). Dissociation
constants Ki and Ki*, the rate constants k3 and k4 and the half-lives t1/2 and reaction energies ∆Ereac
were obtained as described above (see Table 2, see exemplarily Figure 7 for inhibition of cathepsin L by
compound 4, and rhodesain by compounds 3 and 4).
The detailed kinetic data for the two acid derivatives show that the k3 and k4 values, and as a
consequence also t1/2 and ∆Ereac were in the same range for all tested systems. In general, the high
overall inhibition exhibited by the compounds was mainly due to very low off-rates k4 leading to
relatively long half-lives (770–1155 s, i.e., 10–20 min). The differences in the overall inhibition potencies
of the two acid derivatives against the two enzymes (represented by the Ki* values) mainly originated
from the different stabilities of the initial non-covalent complexes [E−−−I], represented by the Ki values
(ca. 400 nM for 3-CathL; ca. 100 nM for 4-CathL; ca. 60 nM for 3-Rhod and ca. 0.4 nM for 4-Rhod).
Thus, the different overall potencies were mainly due to the non-covalent interactions and not to the
covalent second inhibition steps. This is especially apparent for the very strong inhibition of rhodesain
by compound 4: the k3 and k4 values for the second, covalent step were similar to those of the other
enzyme-inhibitor pairs, but the dissociation constant for the initial inhibition step was much lower
(Ki ca. 0.4 nM) than those of the others indicating an extremely stable initial non-covalent complex
[E−−−I] finally leading to an extraordinarily strong overall inhibition (Ki* ca. 0.15 nM).
2.5. Hydrolysis Assays with Benzyl, Methyl and tert-Butyl Esters
As reported previously for benzyl esters of the tested dipeptide sequence [30], we raised the
hypothesis also in the current case, that the observed ester cleavage of the rhodesain–inhibitor
adduct (Figure 5) might occur by rhodesain-catalyzed enzymatic hydrolysis. To verify this hypothesis,
we incubated compounds 1, 2 (benzyl esters), compound 6 (methyl ester) and compound 8 (tert-butyl
ester) for 24 h with rhodesain. The reaction mixtures were subsequently analyzed by LC–MS.
Molecules 2020, 25, 2064 10 of 22
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In fact, we found ester hydr lysis for the benzyl and methyl esters, but not for the tert-butyl
ester. Negative controls without rhodesain showed that the esters were not hydrolyzed by the reaction
buffer. Exemplarily, the LC–MS analysis of compound 1 is shown in Figure 8. The unconverted ester 1
Molecules 2020, 25, 2064 11 of 22
was eluted at tR = 3.19 min. Upon incubation with rhodesain, a peak at tR = 1.03 min was observed
matching the retention time of the reference acid 3. The detected masses matched the theoretical 90 Da
loss of a benzyl group ([cpd1 + H]+ = 559.2 m/z; [cpd3 + H]+ = 469.2 m/z) and the isotopic pattern for
the chlorine substituent demonstrating the rhodesain-catalyzed ester hydrolysis.
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Figure 8. Hydrolysis assay to investigate the ester hydrolysis prodrug concept. (A) Exemplarily,
the chromatograms for cpd. 1 are shown. Cpd. 1 hydrolyzed with rhodesain (blue, tR = 1.03 min)
shows the same retention time as the reference cpd. 3 (green, tR = 1.03 min). The negative control
incubated without rhodesain shows only the educt peak of cpd. 1 (red, tR = 3.19 min). (B) Analysis of
the mass spectrum reveals the loss of a 90 Da fragment, matching the mass and isotopic distribution of
the predicted enzymatic benzyl ester hydrolysis ([cpd1 + H]+ = 559.2 m/z; [cpd3 + H]+ = 469.2 m/z).
These findings again support our previous identification of the benzyl ester prodrug concept
for rhodesain inhibitors [30]: dipeptide-derived benzyl esters containing an electrophilic building
block were hydrolyzed by the target enzyme itself to yield the free acids as highly potent inhibitors.
According to the MS data, which show the m/z peak of the adduct of the enzyme and the complete
free acid, the inhibition proceeds via a nucleophilic addition reaction rather than a combined
addition/elimination (i.e., a substitution) reaction under the loss of chloride or cyanide. This is
in agreement with previous studies on halogen-substituted Michael-acceptors, which showed slow
elimination of the halide only in the case of bromine [17].
In order to determine whether the differences in activity between the benzyl esters and the
methyl ester are due to different rates of hydrolysis catalyzed by rhodesain yielding the acid as much
more potent inhibitor, we followed the reactions spectrophotometrically. Since the esters and the free
carboxylic acid have different UV-Vis characteristics, we recorded time-dependent absorbance spectra
at 400 nm (Figure 9). Plots of absorbance at 400 nm vs. time showed hyperbolic turnover curves for the
benzyl ester (cpd. 2) and the methyl ester (cpd. 6), but not for the tert-butyl ester (cpd. 8) or the free
carboxylic acid (cpd. 4) We were able to show that the benzyl ester (t1/2 = 3.41 min) was hydrolyzed
about three times faster than the methyl ester (t1/2 = 10.2 min), which supports the hypothesis that
in-situ hydrolysis of the benzyl ester to the more active acid may in parts also be responsible for its
inhibitory activity.
Molecules 2020, 25, 2064 12 of 22
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tert-butyl ester (cpd. 8).
2.6. Reaction f Benzyl Esters 1 and 2 with a Low ole t hiol
To further investigate the interaction bet ee t e i ibitors and a low molecular weight thiol
(LMW thiol), the reactions of the esters 1 and 2 with 2-phenylethanethiol in the presence of a base in
ethanol were carried out. It is worth mentioning that, with excess thiol and triethylamine at 80 ◦C,
inhibitor 1 gave the substitution product 9 (Scheme 2) with thiol, which—from a chemical point of
view—could be expected (yield 83%), while inhibitor 2 did not react with the thiol at all under the
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same reaction conditions. These results were in contrast to the reactions of the inhibitors within the
enzyme, which yielded the addition products with the chloro- and the nitrile-substituted inhibitor,
but not the substitution products (see below).
Molecules 2020, 25, x FOR PEER REVIEW 15 of 25 
 
same reaction conditions. These results were in contrast to the reactions of the inhibitors within the 
enzyme, which yielded the addition products with the chloro- and the nitrile-substituted inhibitor, 
but not the substitution products (see below). 
 
Scheme 2. Substitution reaction with 2-phenylethanethiol. 
2.7. Quantum-Mechanical Computations 
All tested compounds contain an activated double bond that could undergo a nucleophilic 
addition or substitution reaction at one of the C-atoms of the α,β-unsaturated carbonyl function with 
the Cys residue of the active site of cysteine proteases. According to the MS studies, an addition 
reaction is displayed by both acids 3 and 4. For unsubstituted naphthoquinones [22], the attack at the 
β-C atom was proposed. It is known from kinase inhibitors [41] and also from cysteine protease 
inhibitors [17] that Michael-acceptor systems can be switched from irreversible nucleophilic addition 
to reversible addition by introduction of an electron-withdrawing group X (X=halogen, nitrile) at the 
α-position [42]. A reversible addition is also observed for the inhibitors presented herein. As 
discussed above, in some cases (X=Br), slow irreversible inactivation was found with such inhibitors 
due to release of the halide anion [17]. On the other hand, nitrile groups are well-known to undergo 
covalent reversible addition reactions with the active site Cys or Ser residues of cysteine and serine 
proteases to yield a thioimidate and imidate, respectively [18,19,20,21]. Taken together, the structures 
of the compounds provide several possibilities (Scheme 3) for reactions with the nucleophilic active 
site Cys residue: reversible nucleophilic attack at one of the carbonyl carbon atoms (Scheme 3: I a,b), 
reversible attack at the nitrile group (II) or attack at one of the C-atoms of the double bond (III, IV). 
From the reversible attack at the nitrile group, compound II results after protonation. In the case of 
the β-attack (III), the reaction should be reversible since an S,N-acetal is produced and elimination of 
the amino group (yielding III b) should not be favored, even after its protonation. In case of the α-
attack (IV), the addition reaction could be either reversible or irreversible (IV a). If an elimination of 
cyanide (or chloride, not shown in the Scheme 3) occurs (IV b) the reaction will become irreversible. 
For the chloro-derivatives, the corresponding products, except II, should be possible. According to 
the MS studies, addition reactions take place within the enzyme for both, the nitrile- and the chloro-
substituted compounds. However, the obvious differences between the reaction with an LMW thiol 
in solution and the reaction within the enzyme have to be considered: with an LMW thiol, the 
substitution reaction takes place with the chloro-substituted ester (path IV b), while the nitrile 
compound is virtually unreactive. 
Scheme 2. Substitution reaction with 2-phenylethanethiol.
2.7. Quantum-Mechanical Computations
All tested compounds contain an activated double bond that could undergo a nucleophilic
addition or substitution reaction at one of the C-atoms of the α,β-unsaturated carbonyl function with
the Cys residue of the active site of cysteine proteases. According to the MS studies, an addition
reaction is displayed by both acids 3 and 4. For unsubstituted naphthoquinones [22], the attack at
the β-C atom was proposed. It is known from kinase inhibitors [40] and also from cysteine protease
inhibitors [17] that Michael-acceptor systems can be switched from irreversible nucleophilic addition
to reversible addition by introduction of an electron-withdrawing group X (X = halogen, nitrile) at the
α-position [41]. A reversible addition is also observed for the inhibitors presented herein. As discussed
above, in some cases (X = Br), slow irreversible inactivation was found with such inhibitors due
to release of the halide anion [17]. On the other hand, nitrile groups are well-known to undergo
covalent r versible ddition reactions with th active site Cys or Ser residues of cysteine and s rine
proteas s to yield a thioimidat and imidate, r pe tively [18–21]. Taken toge r, the structures of the
compounds provide s veral possibilit es (Scheme 3) for reactions with the ucleophilic active site Cys
residu : reversible nucl ophilic attack at one of the carbonyl carbon atoms (Scheme 3: I a,b), reversible
attack at the nitrile group (II) or attack at one of the C-atoms of the double bond (III, IV). From the
reversible attack at the nitrile group, compound II results after protonation. In the case of the β-attack
(III), the reaction should be reversible since an S,N-acetal is produced and elimination of the amino
group (yielding III b) should not be favored, even after its protonation. In case of the α-attack (IV),
the addition reaction could be either reversible or irreversible (IV a). If an elimination of cyanide
(or chloride, not shown in the Scheme 3) occurs (IV b) the reaction will become irreversible. For the
chloro-derivatives, the corresponding products, except II, should be possible. According to the MS
studies, addition reactions take place within the enzyme for both, the nitrile- and the chloro-substituted
compounds. However, the obvious differences between the reaction with an LMW thiol in solution
and the reaction within the enzyme have to be considered: with an LMW thiol, the substitution
reaction takes place with the chloro-substituted ester (path IV b), while the nitrile compound is
virtually unreactive.
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In order to shed some light on possible inhibition mechanisms, we performed quantum-mechanical
(QM) computations of the reaction energies of all possible reactions. In these simulations,
the HN-Phe-Leu-OR/OH group was replaced by HNCH3 and the attacking cysteine group was
mimicked by methanethiol. In the computations, the influence of water was taken into account
through the conductor-like polarizable continuum model (C-PCM) approach [42]. The calculations
were performed with the Gaussian 16 program packages [43]. Our computations only focus on reaction
energies of the reactions in solvents, i.e., kinetic effects, the influence of the enzyme environment
and entropy effects are neglected, which all may influence which reaction path is taken. However,
comparable calculations were previously successfully employed to get insights into the inhibition
mechanisms of various electrophilic warheads such as three-membered heterocycles [44–46] and
Michael-systems [47]. Additionally, more detailed simulations that compute the whole reaction path,
take the molecular nature of the enzyme environment and entropy effects into account and thus can
provide quantitative predictions about the kinetics of the reactions [48,49] are hardly feasible in the
present case because experimental information about the orientation of the inhibitor within the active
site of the enzymes are missing. Table 3 shows possible products and intermediates resulting from the
various reaction paths given in Scheme 3. Please note that III a 1 and III a 4 are enantiomers. The same
holds for III a 2 and III a 3; IV a 1 and IV a 4 as well as IV a 2 and IV a 3. Nevertheless, we present all
data to show that our computations indeed found the same conformers in each case. To ensure that
we computed the lowest conformers we characterized various additional conformers, which were all
higher in energy.
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Table 3. Reactants and products of the reaction of methanethiol with the 1,4-naphthoquinones.
The corresponding products (except II) for the chloro-derivatives are obtained by replacing CN by Cl.
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The experimentally determined reversibility f the inhibition for both, the benzyl esters and
the acids is in line with a reversible ddition to the double bo d becaus backward reactions from
the interm diates I, III a and IV a re possible if th exothermicity of the additi n re cti is small.
The same holds true for the f rm t n of II, which rep esents the product of the ad ition t the
CN group. Such a reaction is also known to be reversible. In contra t, backward reactions from t e
intermediates III b and IV b are unlikely because the corresponding leaving groups cyanide (CN−),
chloride (Cl−) or H2N-R are not expected to reattack the double bond. Their reactivity is low and
they will d ffuse aw y fro the reaction sit after the bon dissociation. Hence, the reacti n paths
III b a d IV b would not be in line with th experim tal findings c nc r i g he re ti n within
the enzyme, which neith r yield d subs i tion prod cts h he enzyme for he hl ro- nor fo the
nitrile- st t ted deri ive . How r, uc a eacti p th is f nd for t c lor - rivative in
r action with a l w ol cul r weight thiol. Thus, these steps should be included in th si ulation
becau an insight into the rela ive energetics f ll rea tion paths answ rs th question if the inhibiti n
mechanism might be steered by substituent effects.
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The computed data for the nitrile are summarized in Table 4 (C-PCM with ε = 78.36).
DFT approaches are known to overestimate stabilization effects in delocalized systems. Consequently,
DFT might considerably overestimate the stability of the reactants and of II, III b and IV b with
respect to the intermediates III a 1-4 and IV a 1-4, i.e., addition-elimination mechanisms would
be erroneously favored with respect to simple addition reactions. Hence, to obtain insights into
the applicability of DFT functionals we compared the predictions of B3LYP-D [50,51], CAM-B3LYP,
CAM-B3LYP-D [52], M06, M06-2X [53] and ωB97-XD [54] with the computed values of the spin
component scaled Møller–Plesset perturbation theory second order (SCS-MP2) approach [55,56].
For the present model computations, we focus on reaction energies (∆Ereac) rather than on free reaction
energies (∆Greac) since the entropy effects are more important for the formation of the non-covalent
reversible enzyme-inhibitor complex, which represents a bimolecular reaction. The chemical reaction
between inhibitor and enzyme, which will take place after the formation of this complex, represents a
unimolecular reaction, i.e., entropy effects are expected to be small within this step.
Table 4. Summary of the reaction energies (∆Ereac) of possible reaction products for the reaction of
the nitrile derivative with methanethiol (Scheme 3, Table 3). All calculations were performed with
6-311++G(d,p) basis sets [57] in combination with the C-PCM approach (solvent = water) to mimic
environmental effects. The structures were previously optimized with ωB97-XD/6-311G(d,p) [58].
All energy values in kcal/mol.
Method SCS-MP2 B3LYP-D CAM-B3LYP CAM-B3LYP-D M06 M06-2X ωB97-XD
II −1.8 −2.8 −0.1 −3.7 −4.5 −4.7 −4.9
III a 1 −8.5 5.5 8.2 2.1 1.1 −1.8 1.2
III a 2 −6.2 6.5 8.9 2.8 1.6 −1.3 2.1
III a 3 −6.2 6.5 8.9 2.8 1.6 −1.3 2.1
III a 4 −8.5 5.5 8.2 2.1 1.1 −1.8 1.2
III b 9.4 15.7 17.3 17.2 15.1 15.2 16.9
IV a 1 −5.2 9.8 12.0 6.3 6.0 2.8 5.6
IV a 2 −1.6 14.0 15.6 10.4 10.3 6.4 9.3
IV a 3 −1.6 14.0 15.6 10.4 10.3 6.4 9.3
IV a 4 −5.2 9.8 12.0 6.3 6.0 2.8 5.6
IV b 8.8 14.0 15.2 13.8 13.7 11.5 13.9
MAE 1 11.6 13.5 9.2 8.6 6.1 8.6
1 Mean average error with respect to SCS-MP2 averaged of all compounds.
According to the presumably most accurate SCS-MP2 approach, the formation of III a 1 and its
enantiomeric form III a 4 were mostly exothermic (∆Ereac = −8.5 kcal/mol). III a 2 and its enantiomeric
form III a 3 were predicted to be less stable. For the attack to the nitrile group (formation of II),
a reaction energy of −1.8 kcal/mol was computed. The most stable isomers of compounds IV a were
IV a 1 and IV a 4 with about −5 kcal/mol. The compounds from which no back-reaction was expected
(III b, IV b) were computed to be very unstable (+9.4 kcal/mol and +8.8 kcal/mol, respectively).
DFT calculations came to different conclusions: All functionals predicted compound II to be lower
in energy than the addition products connected with III a or IV a. The computed stabilities of II
with respect to the reactants varied between −0.1 kcal/mol (CAM-B3LYP) and about −5 kcal/mol
(ωB97-XD). Products resulting from the addition of methanethiol to the activated double bond were
computed to be considerably less stable, in some cases the corresponding reaction was computed to
be endothermic. The difference between the wave function and the DFT-based approaches might
result because many DFT functionals often overestimate stabilities of delocalized systems. Such effects
stabilized the reactants, II, III b and IV b with respect to III a and IV b. This again underlines that the
DFT-based predictions about the reaction mechanisms of warheads have to be regarded with care if
compounds with different degrees of delocalization are involved.
The computations provided insights into the thermodynamics of the possible reaction mechanisms,
however effects arising from the enzyme environments were neglected. Endothermic mechanisms
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were not expected to take place. However, the computations could not predict which of the exothermic
reactions did actually take place since this is also dependent on the environment within the enzyme and
the geometry of the non-covalent enzyme-inhibitor complex. Computations that take these influences
into account, e.g., QM/MM or even QM/MM/MD computations, are only possible when the necessary
crystallographic information of the enzyme–inhibitor complex are available, which was not the case
for the systems presented herein.
The reaction energies obtained from the measured k3 and k4 values for the nitrile-compounds 2
and 4 were between −0.89 and −1.5 kcal/mol. These values fit best to the value for the attack at the
nitrile group computed with SCS-MP2 but the formation of III a or IV a were predicted to be more
exothermic, i.e., they should be formed. However, within an enzyme environment they might become
less favored due to two reasons. Firstly, the orientation of the inhibitor within the active site might
only allow an attack at the nitrile. Additionally, the formation of III or IV might be hampered by
steric effects because the flat sp2 hybridized inhibitor is transformed into a considerably more bulky
form due to the formation of two sp3 centers. Nevertheless, the computations definitely excluded the
formation of intermediates, which should lead to an irreversible enzyme inhibition. This was in line
with the experimental results. It is also important to note that the formation of IV b, which was not
observed in the solvent experiment, was definitively excluded by our computations.
The differences between SCS-MP2 and DFT approaches were even more obvious for the
chloro-substituted 1,4-naphthoquinone (Table 5). As for the nitrile compound, SCS-MP2 predicts that the
formation of compounds III a 1 and its enantiomer III a 4 were most favorable (∆Ereac = −17.3 kcal/mol).
Additionally, as computed for the nitrile compound, other compounds could be formed because their
reactions energies differed only slightly from those of the formation of III a 1 and III a 4. However,
the products that indicate an irreversible substitution reaction (III b and IV b), were again too high
in energy to be formed. In contrast, most DFT functionals predicted the formation of compound
IV b, i.e., the addition to the double bond followed by the elimination of HCl (H+ + Cl− ). Since the
elimination product (i.e., chloride) is expected to diffuse away and because it is not sufficiently reactive
for a reverse reaction, most functionals predicted an irreversible reaction. This was in agreement with
the experimental findings for the reaction of the chloro-derivative with excess LMW thiol in solution in
the presence of a base. The product of this solution reaction corresponds to product IV b in which the
chloride was substituted by the attacking thiol group. Does this result indicate that the DFT functionals
are right while SCS-MP2 is wrong? This is not the case. For III a 1, SCS-MP2 predicted a reversible
reaction, i.e., reactants and products were in equilibrium. The formation of IV b was also predicted
to be exothermic, i.e., this reaction would also take place. Due to the difference in the exothermicity,
IV b was formed to a lower extent, but because this reaction is irreversible while the formation of III a 1
is reversible, finally only the product of the irreversible reaction would be found. For the enzyme
environment, both reactions can be expected to be in equilibrium because the chloride as elimination
product will be formed within the active site of the enzyme, i.e., its diffusion will be strongly hindered.
In this case, the formation of e.g., III a 1 would be considerably favored so that the irreversible reaction
will be suppressed. It is also important to note that our computations are in line with the experimental
observation that in the solvent reaction of an LMW thiol with the chloro-substituted compound the
elimination product IV b was formed while it was not formed for the CN-substituted one.
For the chloro-substituted compound, the experimental and computed reaction energies differed
considerably. This may be owed to the fact that the computations neglected steric as well as electronic
effects arose from the enzyme environment.
According to the QM computations, for both compound classes, namely the chloro and the
nitrile derivatives, the reversible attack of the thiolate at the α- or β-position of the double bond
(yielding products III a or IV a) should be possible. The reaction with a LMW thiol took place at
the α-C atom in case of the chloro derivative (yielding IV b). The experimentally determined ∆Ereac
values for both the chloro and the nitrile derivatives (2–4) were in the same range for both enzymes
(−0.85 to −1.5 kcal/mol, see Table 2). Taken together, it may be hypothesized that for at least the
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chloro-substituted acid, the second covalent inhibition step is the reversible addition of the active-site
Cys residue at the α-position, and furthermore, that this inhibition mechanism might also hold true for
the nitrile-substituted derivatives.
Table 5. Summary of the relative energies of possible reaction products for the reaction of the
chloro-derivative with methanethiol (Scheme 3, Table 3). All calculations were performed with
6-311++G(d,p) basis sets in combination with the C-PCM approach (solvent = water) to mimic
environmental effects. The structures were previously optimized withωB97-XD/6-311G(d,p). All energy
values were in kcal/mol.
Method SCS-MP2 B3LYP-D CAM-B3LYP CAM-B3LYP-D M06 M06-2X ωB97-XD
III a 1 −17.3 −4.6 −1.3 −7.8 −9.0 −11.4 −8.3
III a 2 −13.2 −1.0 1.4 −4.7 −5.7 −8.7 −5.3
III a 3 −13.2 −1.0 1.4 −4.7 −5.7 −8.7 −5.3
III a 4 −17.3 −4.6 −1.3 −7.8 −9.0 −11.4 −8.3
III b 3.8 11.6 12.4 12.3 10.9 9.9 11.7
IV a 1 −13.6 0.8 3.2 −2.6 −3.4 −6.4 −3.6
IV a 2 −11.4 2.6 4.5 −1.1 −1.3 −4.5 −1.6
IV a 3 −11.4 2.6 4.5 −1.1 −1.3 −4.5 −1.6
IV a 4 −13.6 0.8 3.2 −2.6 −3.4 −6.4 −3.6
IV b −8.2 −5.8 −5.0 −6.3 −5.3 −6.9 −6.6
MAE 1 11.7 13.8 8.9 8.2 5.6 8.3
1 Mean average error with respect to SCS-MP2 averaged of all compounds.
2.8. T. b. brucei Cell Survival Assay
Benzyl ester 2 was tested for its antitrypanosomal activity as described previously [59]. With an
EC50 value of 0.12 (±0.013) µM (48 h), the compound was found to exhibit very high antitrypanosomal
activity. This finding is in agreement with previous investigations, which yielded benzyl esters of the
same dipeptidic recognition unit as highly active antitrypanosomal compounds [30]. Again, our results
underlined the hypotheses that the benzyl ester 2 is a prodrug with good cell permeability properties
that is hydrolyzed by its target enzyme yielding the free acid as highly active rhodesain inhibitor.
3. Discussion
In summary, we presented the facile synthesis and detailed investigation of a class of highly
potent protease inhibitors based on 1,4-naphthoquinones carrying a peptidic recognition motif in the
2-position and an electron-withdrawing substituent in the 3-position. A member of this class, namely the
nitrile-substituted compound containing the dipeptide sequence NH-l-Phe-l-Leu-OH, was shown
to be a highly potent inhibitor of rhodesain, an essential protease of a human-pathogenic parasite,
with subnanomolar affinity. To investigate the exact mode of inhibition exerted by this compound
class, detailed kinetic and mass spectrometry studies were used and revealed a time-dependent,
reversible-covalent binding mode. This particular mode is highly attractive in providing long residence
times while at the same time suppressing undesired off-target activity. As found in our previous studies,
which reported inhibitors with the same peptidic recognition unit [30], the respective benzyl ester is
hydrolyzed by the target enzyme itself yielding the free acid. To better understand the physicochemical
basis of the involved processes, we performed calculations with different DFT functionals as well as
wave function-based approaches. These were compared in an extensive analysis in which the SCS-MP2
method, but not the investigated density functional turned out to provide reliable estimates for the
energetics of the possible individual reaction steps. The knowledge gained in this multifaceted study
provides an early step towards the goal of the rational design of new covalent-reversible electrophilic
warheads for enzyme inhibitors. The latter ideally provide desirable pharmacokinetic parameters and
may even confer resistance-breaking properties as already demonstrated for “simple” covalent kinase
inhibitors applied in human oncotherapy.
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